Clinical, Endoscopic and Histological Outcomes in Induction of Moderate-to-Severe Ulcerative Colitis: A Systematic Review with Meta-Analysis

Author:

Magro Fernando1234ORCID,Estevinho Maria Manuela15,Dias Cláudia Camila67,Correia Luís8,Lago Paula9,Ministro Paula10,Portela Francisco11,Feakins Roger12,Danese Silvio1314,Peyrin-Biroulet Laurent15

Affiliation:

1. Department of Biomedicine, Unit of Pharmacology and Therapeutics, Faculty of Medicine, University of Porto, Porto, Portugal

2. Department of Gastroenterology, São João Hospital Center, Porto, Portugal

3. MedInUP, Center for Drug Discovery and Innovative Medicines, Porto, Portugal

4. Clinical Pharmacology Unit, São João Hospital University Center, Porto, Portugal

5. Department of Gastroenterology, Vila Nova de Gaia/Espinho Hospital Center, Vila Nova de Gaia, Portugal

6. Department of Community Medicine, Information and Decision in Health, Faculty of Medicine of the University of Porto, Porto, Portugal

7. Centre for Health Technology and Services Research, Porto, Portugal

8. Department of Gastroenterology and Hepatology, Santa Maria Hospital, University of Lisbon, Lisbon, Portugal

9. Department of Gastroenterology, Porto Hospital Center, Porto, Portugal

10. Department of Gastroenterology, Tondela-Viseu Hospital Center, Viseu, Portugal

11. Department of Gastroenterology, University Hospital Center of Coimbra, Coimbra, Portugal

12. Department of Histopathology, Royal Free London NHS Foundation Trust, London, UK

13. IBD Center, Department of Gastroenterology, Humanitas Clinical and Research Center- IRCCS-, Rozzano, Milan, Italy

14. Department of Biomedical Sciences, Humanitas University, Pieve Emanuele, Milan, Italy

15. Institut National de la Santé et de la Recherche Médicale U954 and Department of Gastroenterology, Nancy University Hospital, Lorraine University, Nancy, France

Abstract

Abstract Background and Aims Interest in histology for ulcerative colitis [UC] has increased recently. This systematic review and meta-analysis aims to assess, for the first time, whether histological outcomes are more informative than endoscopic and clinical outcomes in distinguishing the impact of intervention over placebo in induction trials. Methods MEDLINE, ScienceDirect and Cochrane Central Register of Controlled Trials were searched to identify randomized placebo-controlled trials [RCTs] enrolling moderate-to-severe UC patients. Studies were assessed using the Quality Assessment Tool for Studies with Diverse Designs. We analysed the pooled proportion of patients achieving clinical, endoscopic and histological remission and response after a pharmacological intervention and compared the results with those of placebo-treated patients by using a random-effects model. Results From 889 identified records, 13 RCTs were included. The odds ratio [OR] for remission was higher in patients receiving intervention than in those under placebo for clinical (OR 2.13, 95% confidence interval [CI] 1.33–3.43), endoscopic [OR 1.46, 95% CI 0.19–11.18] and histological remission [OR 1.85, 95% CI 1.20–2.84]. Significant differences were observed for all response outcomes [clinical: OR 2.27, 95% CI 1.84–2.85; endoscopic: OR 2.16, 95% CI 1.51–3.10; histological: OR 3.63, 95% CI, 1.41–9.36]. No significant heterogeneity existed; no subgroup effects were found for duration of the induction or histological scale [p > 0.05]. Clinical and histological remission and endoscopic response were concordant in discriminating interventions from placebo. Conclusion Histological outcomes are informative in trials of moderate-to-severe UC. Further studies analysing histology at the end of induction are needed to confirm its relevance in distinguishing the efficacy of an intervention over placebo in comparison to clinical and endoscopic outcomes and to explore its prognostic value.

Funder

Portuguese Group of Studies in Inflammatory Bowel Disease

Publisher

Oxford University Press (OUP)

Subject

Gastroenterology,General Medicine

Reference51 articles.

1. Prognostic value of histological activity in patients with ulcerative colitis in deep remission: A prospective multicenter study;Lobatón;United Eur Gastroenterol J,2018

2. A treat-to-target update in ulcerative colitis: a systematic review;Ungaro;Am J Gastroenterol,2019

3. European Crohn’s and Colitis Organisation Topical Review on Treatment Withdrawal [’Exit Strategies’] in Inflammatory Bowel Disease;Doherty;J Crohn’s Colitis,2017

4. A multicentre prospective cohort study assessing the effectiveness of budesonide MMX® (Cortiment®MMX®) for active, mild-to-moderate ulcerative colitis;Danese;United Eur Gastroenterol J,2019

5. Comparison of the EMA and FDA guidelines on ulcerative colitis drug development;Reinisch;Clin Gastroenterol Hepatol,2018

Cited by 10 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3